Research
Hormonal
Semaglutide, a GLP-1 receptor agonist, can lead to weight reductions of up to 15%.
Practitioners should consider the potential effectiveness of semaglutide for weight loss in patients.
StrongSupportsmedium confidence
The introduction of semaglutide, a glucagon-like-1 receptor agonist (GLP-1ra) as a weight-loss medication, has attracted considerable public and medical attention, reporting weight reductions of up to 15%.
Why this rating
The study is based on ethnographic fieldwork, providing direct observational evidence.
Source
Tinkering with weight loss medication in clinical encounters: An ethnographic study
Sissel Due Jensen et al. · Social Science & Medicine · 2025
otherCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →